PANZYGA

Manufacturer:

PFIZER INC.

Name:

PANZYGA

HCPCS Code Descriptor:

Injection, immune globulin (panzyga), intravenous, non-lyophilized (e.g., liquid), 500 mg

Category:

J Code

HCPCS:

J1576

NDC(s):

68982-0822-06, 68982-0822-05, 68982-0822-03, 68982-0822-04, 68982-0822-02, 00069-1558-02, 00069-1415-02, 00069-1312-02, 00069-1224-02, 00069-1109-02

Primary Type:

Immunoglobulin

Generic Status:

Multi-Source

Route of Administration:

Intravenous

About:

PANZYGA is a Immunoglobulin drug manufactured by PFIZER INC. and administered via the Intravenous route of administration. The J Code: J1576 is aligned to the drug PANZYGA.

Panzyga is an immunoglobulin medication that works by using human blood containing high levels of antibodies. Panzyga can be used to aid the patient’s immunes system and can also be used to treat certain neurological disorders. This medication is manufactured by Octapharma and Pfizer. The J code: J1576 was aligned to this medication in July of 2023 under the 505(B)(2) pathway. The NDCs aligned to this code were previously aligned to the miscellaneous code for Panzyga: J1599. Patient assistance programs for this medication can be found through Panzyga’s website.